Minerva Surgical, Inc.
UTRS · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $29,281 | $45,305 | $21,026 | $13,869 |
| - Cash | $11,125 | $15,713 | $25,255 | $6,942 |
| + Debt | $43,551 | $43,625 | $39,542 | $39,690 |
| Enterprise Value | $61,707 | $73,217 | $35,313 | $46,617 |
| Revenue | $11,965 | $13,391 | $12,533 | $13,804 |
| % Growth | -10.6% | 6.8% | -9.2% | – |
| Gross Profit | $6,218 | $7,402 | $7,015 | $7,371 |
| % Margin | 52% | 55.3% | 56% | 53.4% |
| EBITDA | -$4,560 | -$5,530 | -$10,240 | -$5,208 |
| % Margin | -38.1% | -41.3% | -81.7% | -37.7% |
| Net Income | -$7,181 | -$8,681 | -$13,444 | -$6,245 |
| % Margin | -60% | -64.8% | -107.3% | -45.2% |
| EPS Diluted | -0.81 | -0.98 | -2.81 | -2.01 |
| % Growth | 17.3% | 65.1% | -39.8% | – |
| Operating Cash Flow | -$5,095 | -$9,608 | -$8,386 | -$15,644 |
| Capital Expenditures | -$17 | -$13 | -$75 | $36 |
| Free Cash Flow | -$5,112 | -$9,621 | -$8,461 | -$15,608 |